source
- Arbitration panel rules Prime Medicine did not breach Beam deal over AATD therapyAn arbitration panel has ruled that Prime Medicine did not violate its 2019 collaboration agreement with Beam Therapeutics by advancing a treatment for alpha‑1 antitrypsin deficiency (AATD). The de…
- ACA insurers seek median 14% premium hike for 2027 as enrollment fallsInsurers filing with state regulators for 2027 ACA plans are asking for a median premium increase of 14%, according to an analysis of filings in 16 states and the District of Columbia. This would…